DeepMed Research

University Health Network

🇨🇦Canada

Country: 🇨🇦Canada

Ownership: Private

Established: 1999-01-01

Employees: 10K

Market Cap: -

Website: http://www.uhn.ca

Clinical Trials

Relationship of Point-of-care Coagulation Assays with Clinical Outcomes in Cardiac Surgery: a Retrospective Cohort Study

Not yet recruiting

Conditions: Cardiac Surgery Requiring Cardiopulmonary Bypass

First Posted Date: 2025-03-19

Last Posted Date: 2025-03-19

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 15000

Registration Number: NCT06882759

Cannabinoids for Osteoarthritis Pain Effectiveness Trial

Not Applicable

Not yet recruiting

Conditions: Osteoarthritis of Knee
Osteoarthritis Hip

Interventions: Drug: CBD
Drug: THC
Drug: Placebo

First Posted Date: 2025-03-17

Last Posted Date: 2025-05-21

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 100

Registration Number: NCT06878417

Locations: 🇨🇦
University Health Network, Toronto, Ontario, Canada
🇨🇦
Women's College Hospital, Toronto, Ontario, Canada
🇨🇦
McGill University Health Centre/Montreal General Hospital, Montreal, Quebec, Canada

Canada-wide Implementation of a Virtual Sexual Health and Rehabilitation eClinic (SHAReClinic) for Prostate Cancer Patients and Their Partners

Recruiting

Conditions: Prostate Cancer
Sexual Dysfunction, Physiological
Sexual Dysfunction, Psychological
Sexual Dysfunction
Virtual Care
Virtual Clinic
Survivorship
Implementation of Evidence Based Programs
Implementation

First Posted Date: 2025-03-14

Last Posted Date: 2025-03-14

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 575

Registration Number: NCT06877598

Locations: 🇨🇦
Vancouver Coastal Health Authority, Vancouver, British Columbia, Canada
🇨🇦
Men's Health Clinic Manitoba, Winnipeg, Manitoba, Canada
🇨🇦
Royal Victoria Regional Health Centre, Barrie, Ontario, Canada

and more 7 locations

PET/MR Scan With [68Ga]Ga-PentixaFor (CXCR4) vs Standard of Care (SOC) for Initial Staging and Follow up in Multiple Myeloma (MM)

Not Applicable

Not yet recruiting

Conditions: Multiple Myeloma

Interventions: Drug: [68Ga]Ga-PentixaFor

First Posted Date: 2025-03-11

Last Posted Date: 2025-03-11

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 30

Registration Number: NCT06871176

Locations: 🇨🇦
University Health Network, Toronto, Ontario, Canada

Dose Efficacy in Adhesive Capsulitis

Phase 3

Recruiting

Conditions: Adhesive Capsulitis of the Shoulder

Interventions: Drug: 40 mg Methylprednisolone
Drug: 80 mg Methylprednisolone

First Posted Date: 2025-02-27

Last Posted Date: 2025-02-27

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 40

Registration Number: NCT06848374

Locations: 🇨🇦
Toronto Rehabilitation Institution, Toronto, Ontario, Canada

Elective Adaptive Radiation With SBRT for Improved DurabilitY of Response

Not Applicable

Not yet recruiting

Conditions: Prostate Adenocarcinoma
Iliac Nodal Disease
Para-aortic Lymph Node Metastasis
Para-aortic Nodal Disease
Oligorecurrence

First Posted Date: 2025-02-17

Last Posted Date: 2025-03-04

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 26

Registration Number: NCT06831032

Locations: 🇨🇦
Princess Margaret Cancer Centre, Toronto, Ontario, Canada

Is Adaptive SBRT for Prostate vs Image-guided Radiotherapy a True Evolution (ASPIRE)

Phase 3

Recruiting

Conditions: Localized Prostate Cancer
Stereotactic Body Radiotherapy

First Posted Date: 2025-02-13

Last Posted Date: 2025-02-18

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 320

Registration Number: NCT06825091

Locations: 🇨🇦
Princess Margaret Cancer Center, Toronto, Ontario, Canada

BAL Fluid Biomarkers in Sarcoma

Phase 2

Not yet recruiting

Conditions: Soft Tissue Sarcoma (STS)
Bronchoalveolar Lavage (BAL)
Bronchoalveolar Lavage Fluid

First Posted Date: 2025-02-07

Last Posted Date: 2025-03-06

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 70

Registration Number: NCT06815666

Locations: 🇨🇦
Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada

ctDNA-Guided CURB for OPD mNSCLC on TKI (CURB-TKI)

Phase 2

Not yet recruiting

Conditions: Metastatic NSCLC - Non-Small Cell Lung Cancer
OligoProgressive Metastatic Disease

First Posted Date: 2025-02-07

Last Posted Date: 2025-03-06

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 60

Registration Number: NCT06813664

Locations: 🇨🇦
Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada

Using Tumor Models to Determine Treatments

Phase 2

Not yet recruiting

Conditions: Pancreatic Ductal Carcinoma
Advanced Cancer
Epithelial Tumor

Interventions: Drug: Cobimetinib
Drug: Ponatinib
Drug: Brigatinib
Drug: Colchicine
Drug: Selinexor
Drug: Abemaciclib
Drug: Neratinib
Drug: Doxorubicin
Drug: Etoposide
Drug: Ceritinib

First Posted Date: 2025-02-06

Last Posted Date: 2025-02-18

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 25

Registration Number: NCT06813079

Locations: 🇨🇦
Princess Margaret Cancer Centre, Toronto, Ontario, Canada

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy